Meetings - The ASCO Post

/ First-Line HCC in Focus: Survival, Safety, and Real-World Evidence

Case 3: Metastatic Hepatocellular Carcinoma After Failure of First-Line Immunotherapy

This is Part 3 of First-Line HCC in Focus: Survival, Safety, and Real-World Evidence, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video...

hepatobiliary cancer

/ First-Line HCC in Focus: Survival, Safety, and Real-World Evidence

Case 2: Metastatic Hepatocellular Carcinoma

This is Part 2 of First-Line HCC in Focus: Survival, Safety, and Real-World Evidence, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video...

hepatobiliary cancer

/ First-Line HCC in Focus: Survival, Safety, and Real-World Evidence

Case 1: Liver-Limited Hepatocellular Carcinoma

This is Part 1 of First-Line HCC in Focus: Survival, Safety, and Real-World Evidence, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video,...

First-Line HCC in Focus: Survival, Safety, and Real-World Evidence

Case 3: Metastatic Hepatocellular Carcinoma After Failure of First-Line Immunotherapy

Case 2: Metastatic Hepatocellular Carcinoma

Case 1: Liver-Limited Hepatocellular Carcinoma

GLP-1 Receptor Agonists Linked to Lower Colorectal Cancer Risk in Patients With IBD

Intraoperative Margin Assessment With Specimen PET/CT Imaging in Early Breast Cancer

No Survival Benefit From Chemoradiotherapy After D2 Gastrectomy in Gastric Cancer

All-Oral Combination of Revumenib, Decitabine/Cedazuridine, and Venetoclax for Relapsed or Refractory AML

Investigators Identify Resistance Mechanism to Tagraxofusp Among Patients With BPDCN